Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainhoa Lapitz

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targetsAlvaro Santos-Laso, Laura Izquierdo-Sanchez, Pedro M Rodrigues, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Gut|August 5, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potentialMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targetsAlvaro Santos-Laso, Laura Izquierdo-Sanchez, Pedro M Rodrigues, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Journal of Hepatology|May 5, 2025
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasIrene Olaizola, Mikel Odriozola-Gimeno, Paula Olaizola, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Gut|August 5, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potentialMaria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, et al.
Pageof 2